Safety of Spinal Anesthesia in Patients with Mitral Valve Prolapse
Preoperative Assessment
- The American College of Cardiology recommends stratifying patients with mitral valve prolapse based on severity, with Stage A being mild MVP with normal coaptation and no mitral regurgitation, Stage B being progressive MVP with normal coaptation and mild-to-moderate MR, Stage C being severe MVP with loss of coaptation or flail leaflet and severe MR, and Stage D being symptomatic severe MVP with MR 1
- Key factors to evaluate before proceeding with spinal anesthesia include presence and severity of mitral regurgitation, left ventricular size and function, pulmonary artery pressure, and presence of symptoms such as dyspnea, fatigue, and palpitations 1, 2, 3
Anesthetic Considerations
- The American College of Cardiology recommends that patients with mild MVP (Stage A) without MR can safely undergo spinal anesthesia, while patients with moderate-to-severe MVP (Stages B-D) require careful hemodynamic management 4, 5
- Maintaining adequate heart rate is crucial, as excessive bradycardia can worsen MR in MVP patients, and arrhythmias can be precipitated by anesthesia 4
Special Considerations
- Patients with MVP and atrial fibrillation require anticoagulation management if they are on warfarin therapy, and for patients with severe symptomatic MR (Stage D), optimizing medical therapy before elective procedures is recommended 3, 1, 6
Recommendations for Anesthetic Management
- For mild MVP without MR (Stage A), standard spinal anesthesia technique is appropriate, while for MVP with mild-to-moderate MR (Stage B), gradual induction of spinal anesthesia and maintaining adequate preload with fluid management is recommended 4, 5
- For MVP with severe MR (Stages C and D), considering alternative anesthetic techniques or modified approach to spinal anesthesia, maintaining higher than normal preload, and avoiding tachycardia is crucial 4, 5
- Prophylactic beta-blockers may be considered for patients with history of arrhythmias 7